Background Cigarette smoking remains a primary cause of chronic lung diseases. After a steady decline, smoking rates have recently increased especially with the introduction of newer electronic nicotine delivery devices, and it is also emerging that dual- or poly-product usage is on the rise. Additionally, with the introduction of IQOS (a heated tobacco product) globally, its impact on human health needs to be investigated. In this study we tested if dual exposure (cigarette smoke (CS)+IQOS) is detrimental to lung epithelial cells when compared with CS or IQOS exposure alone. Methods Human airway epithelial cells (BEAS-2B) were exposed to either CS, IQOS or their dual combination (CS+IQOS) at concentrations of 0.1%, 1.0%, 2.5% and 5.0%. Cyt...
In the present study, we evaluated the acute response of mice exposed to IQOS aerosol, a brand-name ...
Many studies have been undertaken to reveal how tobacco smoke skews immune responses contributing to...
Exposure to cigarette smoke (CS) is the primary risk factor for developing chronic obstructive pulmo...
While cigarette smoking still remains one of the most pressing global health issues of our time, new...
Introduction: Recently, the Food and Drug Administration (FDA) authorized the marketing of IQOS Toba...
Background: Smoking and aberrant epithelial responses are risk factors for lung can...
IntroductionVentilator-induced lung injury (VILI) impacts clinical outcomes in acute respiratory dis...
Recently, the Food and Drug Administration authorized the marketing of IQOS Tobacco Heating System a...
Background Cigarette smoking is the major risk factor for COPD, leading to chronic airway inflammati...
Abstract Background This study has investigated the ability of tobacco smoke, and ingredients of tob...
The human body encounters a number of chemical exposures on a daily basis, which may have short- or ...
This study compared the cytotoxicity of IQOS aerosols to smoke from Marlboro Red (MR) and 3R4F refer...
Background: Cigarette smoke extract (CSE), a model for studying the effects of tobacco smoke in vivo...
In the present study, we evaluated the acute response of mice exposed to IQOS aerosol, a brand-name ...
Many studies have been undertaken to reveal how tobacco smoke skews immune responses contributing to...
Exposure to cigarette smoke (CS) is the primary risk factor for developing chronic obstructive pulmo...
While cigarette smoking still remains one of the most pressing global health issues of our time, new...
Introduction: Recently, the Food and Drug Administration (FDA) authorized the marketing of IQOS Toba...
Background: Smoking and aberrant epithelial responses are risk factors for lung can...
IntroductionVentilator-induced lung injury (VILI) impacts clinical outcomes in acute respiratory dis...
Recently, the Food and Drug Administration authorized the marketing of IQOS Tobacco Heating System a...
Background Cigarette smoking is the major risk factor for COPD, leading to chronic airway inflammati...
Abstract Background This study has investigated the ability of tobacco smoke, and ingredients of tob...
The human body encounters a number of chemical exposures on a daily basis, which may have short- or ...
This study compared the cytotoxicity of IQOS aerosols to smoke from Marlboro Red (MR) and 3R4F refer...
Background: Cigarette smoke extract (CSE), a model for studying the effects of tobacco smoke in vivo...
In the present study, we evaluated the acute response of mice exposed to IQOS aerosol, a brand-name ...
Many studies have been undertaken to reveal how tobacco smoke skews immune responses contributing to...
Exposure to cigarette smoke (CS) is the primary risk factor for developing chronic obstructive pulmo...